SCHEMBL4147764

SCHEMBL4147764

O=C(c1ccc(O)cc1O)N1CCCC(CCOc2ccccc2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 6/20 0.48
HSP90AB1 P08238 6/20 0.48
TEAD1 P28347 1/20 0.46
TEAD3 Q99594 1/20 0.46
ALDH1A1 P00352 3/20 0.44
HPGD P15428 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
AKR1C3 P42330 1/20 0.41
MAOB P27338 2/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4151298 0.79 ALDH1A1 (0.45) HSP90AA1HSP90AB1ALDH1A1HPGDLMNA
SCHEMBL4151901 0.77 SPR (0.62) HSP90AA1HSP90AB1PDK1GRIN2DGRIN3B
SCHEMBL4151317 0.74 SPR (0.60) HSP90AA1HSP90AB1GRIN2DGRIN3BGRIN1
SCHEMBL4157825 0.74 KMT2A (0.53) ALDH1A1HPGD
SCHEMBL4150930 0.74 PDK1 (0.57) HSP90AA1HSP90AB1PDK1
SCHEMBL2789468 0.73 TEAD1 (0.66) TEAD1TEAD3ALDH1A1HPGDLMNA
SCHEMBL4143175 0.73 HSP90AA1 (0.62) HSP90AA1HSP90AB1ALDH1A1HPGD
SCHEMBL4155107 0.72 HSP90AA1 (0.50) HSP90AA1HSP90AB1ALDH1A1HPGDPDK1
SCHEMBL4150661 0.72 GRIN2D (0.45) HSP90AA1HSP90AB1MAOBGRIN2DGRIN3B
SCHEMBL4151230 0.72 SCD5 (0.56) HSP90AA1HSP90AB1PDK1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US claimed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP claimed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO claimed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP disclosed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HSP90AB1 1/4885TEAD1 4147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.